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Background
Blood-brain barrier (BBB) dysfunctions have been impli-
cated in the development and progression of Alzheimer’s
disease. Cerebral endothelial cells (CECs) and astrocytes
are the main cell components of the BBB. Although amy-
loid-b oligomers have been reported to mediate oxidative
damage to the CECs and astrocytes and trigger the down-
stream MAPK/ERK pathway, the cell surface binding site
for Ab and exact sequence of these events have yet to be
elucidated. In this study, the receptor for advanced glyca-
tion endproducts (RAGE) was postulated to function as a
signal transducing cell surface receptor for Ab to induce
ROS generation from NADPH oxidase and trigger
downstream pathways for the phosphorylation of
extracellular-signal-regulated kinases (ERK1/2) and
cytosolic phosphorilase A2 (cPLA2).
Materials and methods
Immortalized CECs (bEnd3) and primary rat astrocytes
were applied in this study. To confirm Ab-RAGE binding,
we examined the quantitative immunofluorescence micro-
scopy (QIM) of cellular surface RAGE for primary astro-
cytes and bEnd3 cells pretreated with oligomeric Ab1-42
at +4°C (conditions in which the internalization of surface
receptors is suppressed) and stained with antiRAGE pri-
mary antibody (AbRAGE). To quantify the ROS production,
we applied fluorescence microscopy of dihydroethidium
(DHE) in the cells. Confocal immunofluorescence micro-
scopy of double immunofluorescent labeled gp91-phox
and p47-phox subunits was performed to characterize
NADPH oxidase complex assembly. Western blot analysis
was applied to characterize phosphorylation of cPLA2a.
Results
We report that Ab42 competed with the anti-RAGE anti-
body (AbRAGE) to bind to RAGE on the surfaces of CECs
and primary astrocytes. In addition, AbRAGE abrogate
Ab42-induced ROS production and the co-localization
between the cytosolic (p47-phox) and membrane
(gp91-phox) subunits of NADPH oxidase in both cell
types. AbRAGE, as well as NADPH oxidase inhibitor and
ROS scavenger suppressed Ab42-induced ERK1/2 and
cPLA2 phosphorylation in CECs. At the same time, only
AbRAGE, but not NADPH oxidase inhibitor or ROS scaven-
ger, inhibited ERK1/2 and cPLA2a phosphorylation in
primary astrocytes.
Conclusions
This study demonstrated that Ab42 binding to RAGE on the
CEC and astrocyte surfaces is required for NADPH oxidase
complex assembling, resulting in subsequent ROS genera-
tion and phosphorylation of ERK1/2 and cPLA2 and sug-
gested the presence of two different RAGE-dependent
downstream pathways in CECs and astrocytes. Therefore,
understanding precise molecular mechanisms underlying
Ab mediated oxidative damage may provide new insights
into the development of preventive and treatment strategies
for AD.
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